RT Journal Article
SR Electronic
A1 Cunningham, Muriel
T1 ISAR-SAFE: No Difference in 6-Month vs 12-Month DAPT after DES
JF MD Conference Express
YR 2014
FD SAGE Publications
VO 14
IS 52
SP 13
OP 14
DO 10.1177/155989771452005
UL http://mdc.sagepub.com/content/14/52/13.abstract
AB Current treatment guidelines recommend that patients undergoing drug-eluting stent percutaneous coronary intervention take dual antiplatelet therapy (DAPT) consisting of aspirin plus an adenosine diphosphate receptor inhibitor for at least 12 months after the procedure. The Safety and Efficacy of Six Months Dual Antiplatelet Therapy After Drug-Eluting Stenting [ISAR-SAFE] trial was designed to determine whether 6 months of DAPT treatment was non-inferior to 12 months, as discussed in this article.